Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma
M. F. Orth, J. S. Gerke, T. Knosel…·T. G. P. Grunewald
This study identifies AMPD2 as a prognostic biomarker for undifferentiated pleomorphic sarcoma using transcriptome analysis, immunohistochemistry, and functional assays.